Skip to main content
Premium Trial:

Request an Annual Quote

Counsyl Lays Off 27 Employees

NEW YORK (GenomeWeb) – Molecular diagnostic company Counsyl has laid off 27 people, or about 6 percent of its more than 400-employee workforce, the firm said today.

In a statement, CEO Ramji Srinivasan said that the firm made the decision in order to "structure the company around advancing our relationships with clinicians and medical providers." The 27 employees who were laid off worked in sales support, marketing, design, and engineering.

Srinivasan added that the firm is hiring for "targeted roles" that support the development of clinical relationships in "commercial sales and clinical marketing."

South San Francisco, California-based Counsyl offers next-generation sequencing-based carrier screening, noninvasive prenatal testing, and inherited cancer screening.

Srinivasan said in the statement that the layoffs are not a result of stagnant test growth and that the firm has "double-digit" growth in its carrier screening product, as well as "rapid uptake" of its NIPT and inherited cancer tests.

In January, Srinivasan told investors at the JP Morgan Healthcare conference in San Francisco that the company had tested more than 500,000 patients. At the time, he also said that Counsyl was "poised for expansion into new markets," such as the somatic cancer market, and that it was developing a liquid biopsy assay.

The company did not confirm whether the recent layoffs were related to a potential expansion into the somatic cancer market.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.